PRNewsWire
26 Feb 2026, 21:55 UTC · 29w ago
Verdict
Headline leans bearish. We score PRCT −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
PROCEPT BioRobotics reported quarterly revenue 19% below forecasts and 2026 annual sales guidance 5% below expectations.
More negative than 99% of claims this week
Ademi LLP is investigating PROCEPT BioRobotics for possible securities fraud regarding inaccurate statements on financial statements and business prospects.
Continue reading
5 related stories
More negative than 96% of ticker scores this week
Scored by the NIS engine · methodology.
Search tags
More negative than 94% of claims this week
The company discontinued quarter-end promotional discounts for its disposable handpieces, which previously drove significant portions of sales.
More negative than 86% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is being investigated for possible securities fraud and has reported revenue and guidance below expectations.
More negative than 89% of ticker scores this week
The company is under investigation for possible breaches of fiduciary duty.
More negative than 89% of ticker scores this week
The company is under investigation for possible breaches of fiduciary duty.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−21.7%
Price agrees with the score
$18.51 vs $23.63 close before publication (Feb 26) · not market-adjusted
PRCT chart →